pooled analysis · 2015 · landmark
“The prevalence of amyloid pathology increased from age 50 to 90 years from 10% (95% CI, 8%-13%) to 44% (95% CI, 37%-51%) among participants with normal cognition; from 12% (95% CI, 8%-18%) to 43% (95% CI, 32%-55%) among patients with SCI; and from 27% (95% CI, 23%-32%) to 71% (95% CI, 66%-76%) among patients with MCI.”
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA
Who: Individual participant data from 55 PET/CSF biomarker studies: 2914 participants with normal cognition, 697 with subjective cognitive impairment and 3972 with MCI, aged 18 to 100 years
PMID 25988462